- Home
- TIL vs GROV Comparison
TIL vs GROV Comparison
Compare TIL & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TIL | GROV |
|---|---|---|
| Founded | 2018 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.2M | 44.8M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TIL | GROV |
|---|---|---|
| Price | $6.11 | $0.99 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.6K | ★ 63.8K |
| Earning Date | 11-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 6.06 | ★ 55.26 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $173,716,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $8.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.67 | $0.86 |
| 52 Week High | $20.32 | $1.57 |
Technical Indicators
Market Signals| Indicator | TIL | GROV |
|---|---|---|
| Relative Strength Index (RSI) | 30.65 | 42.15 |
| Support Level | N/A | $0.99 |
| Resistance Level | $8.10 | $1.11 |
| Average True Range (ATR) | 0.31 | 0.05 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 15.23 | 26.07 |
Price Performance
Historical ComparisonAbout TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is a digital-first, sustainability-oriented consumer products innovator specializing in the development and sale of household, personal care, beauty and other consumer products with a human and environmental focus. The Company sells its products through a direct-to-consumer (DTC) platform and the Company's mobile applications, where the Company sells products from Grove-owned brands (Grove Brands) and third-parties.